Atopic dermatitis: a candidate for disease-modifying strategy
about
Atopic Dermatitis and Respiratory Allergy: What is the LinkImmune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted TherapeuticsAtopic dermatitis and skin allergies - update and outlookNew Developments in Biomarkers for Atopic DermatitisThe Long-Term Course of Atopic Dermatitis.The first thousand days - intestinal microbiology of early life: establishing a symbiosis.International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem.Atopic dermatitis phenotypes in childhoodNew insights into the epidemiology of childhood atopic dermatitis.Protein biomarkers in vernix with potential to predict the development of atopic eczema in early childhood.Food allergy enhances allergic asthma in miceDanggui buxue tang inhibits 2,4-dinitrochlorobenzene: induced atopic dermatitis in mice.Association of variation in the LAMA3 gene, encoding the alpha-chain of laminin 5, with atopic dermatitis in a German case-control cohort.Early-onset atopic dermatitis in children: which are the phenotypes at risk of asthma? Results from the ORCA cohortClinical Characteristics, Treatments, and Prognosis of Atopic Eczema in the Elderly.Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part I): General Management and Topical Treatment.Exploring the origins of asthma: Lessons from twin studiesIn a three-dimensional reconstructed human epidermis filaggrin-2 is essential for proper cornification.Prevention of atopic dermatitis.Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine.Update in clinical allergy and immunology.Immunopathogenesis of allergic disorders: current concepts.Immunology of atopic eczema: overcoming the Th1/Th2 paradigm.Functional textiles for atopic dermatitis: a systematic review and meta-analysis.Lipid abnormalities and lipid-based repair strategies in atopic dermatitis.Fungi: the neglected allergenic sources.New approaches to the prevention of childhood atopic dermatitis.Immunological and molecular targets of atopic dermatitis treatment.Metabolomics approach in allergic and rheumatic diseases.Off-label prescriptions for atopic dermatitis in Europe.Update on skin allergy.The contribution of biotechnology toward progress in diagnosis, management, and treatment of allergic diseases.Recent advances in epidemiology and prevention of atopic eczema.Unravelling the complex genetic background of atopic dermatitis: from genetic association results towards novel therapeutic strategies.The Genetics and Epigenetics of Atopic Dermatitis-Filaggrin and Other Polymorphisms.New opportunities and challenges in the assessment of drugs for atopic diseases.Characterization of different courses of atopic dermatitis in adolescent and adult patients.Expression of the filaggrin gene in umbilical cord blood predicts eczema risk in infancy: A birth cohort study.Plasmodium berghei infection ameliorates atopic dermatitis-like skin lesions in NC/Nga mice.[Pathophysiology of atopic blepharokeratoconjunctivitis].
P2860
Q26777215-59DD623A-35D0-49ED-826F-0A09D84BCB5CQ26799532-DF0E3C7E-B7F5-4E1B-A923-05F7A4ABB5F1Q26851924-AF32A5CD-C098-406D-9450-F8A6EAEE7E1FQ28396611-9DF74A50-53DA-4C83-8C06-22E8D502B579Q30234105-A3545305-ACA2-4494-8585-4E9CF002D0B4Q31162899-A0497465-A6FD-4D74-A733-AEA121F19613Q33572979-8BD11D72-C809-4452-8E5E-E4DE954A2F30Q33776717-7EC63F62-2468-42E2-BB1B-0B51365C70D5Q34397465-D20CF2C1-440B-450D-8964-036E4D956642Q34482148-C5FD882E-F8C9-4119-9011-418F5BEB0BB6Q34631164-49E73201-D765-45AD-9814-D424C85C390FQ35227144-4DCCE517-061A-44FA-858C-1DD564F532D6Q35386033-455CD012-DB2D-485D-AB85-03B2637BD57BQ35673293-DACD5C5E-1302-48A2-97DD-EECD6627B481Q35750607-22CF55DF-B99B-4055-A42C-89D7818A1F29Q36214247-EA960C60-C2F0-4843-946C-2A2070759F91Q36239426-4C66E420-3AB3-4985-8C6E-E333778E82EBQ36347302-D700A1A6-D52A-4487-B583-B37B3FB01686Q36449701-EA48FF46-69CA-4CB2-AB9F-01C04A771357Q38056156-305B8E94-DB23-43CD-9158-3D0C5FB403C1Q38056516-6D5620EF-17AA-414F-B70C-BDAD960FAB3EQ38085051-9A065827-3FD2-4E85-B5C6-E6B2E87C4B07Q38124385-774ACC0D-33A1-47E7-BA40-888CBFA46472Q38131812-08922828-C4DF-40A9-A559-5DAD9798A461Q38152889-94349117-0BB6-4A86-8ABA-5936462DB7EBQ38167038-A3FC71C9-1BC1-4826-B6D5-B8EDF31A070EQ38174084-4A16722C-609A-46D6-B04C-0CA081E52656Q38203601-76903C07-FE73-4F02-BB6D-A5DA01319E33Q38205414-F6FAC49A-8043-40B4-94F2-8DB4DCC2449DQ38235225-DE56F0C8-B97B-4CFE-BB8B-4F833424B16EQ38256777-7054AB19-7226-4E84-B5CB-D3EE24A763D6Q38259275-155E5B80-DDC0-4EB6-84F1-BFD842F14922Q38269231-23A7410A-EC21-4F85-A38C-FAF3E493FA3AQ38360676-637ED5B1-8F1E-4FB2-A7F9-EA5F458EA17AQ38589257-34D8B3FF-CC17-4790-9C01-01F40289A030Q38813651-6022A206-9C1E-469A-AAFD-39F3B488E94DQ39459070-B8ADC3A9-468D-4B53-81EE-3939062ED3F8Q40202268-DC23E95C-31E5-46A0-BEEC-CD0FE9EAE5E1Q40203895-9CD4AE41-2F54-44E5-859D-9D268720F048Q40265910-72520881-79B6-41CC-8EC4-FE4E4BA77645
P2860
Atopic dermatitis: a candidate for disease-modifying strategy
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Atopic dermatitis: a candidate for disease-modifying strategy
@ast
Atopic dermatitis: a candidate for disease-modifying strategy
@en
Atopic dermatitis: a candidate for disease-modifying strategy
@nl
type
label
Atopic dermatitis: a candidate for disease-modifying strategy
@ast
Atopic dermatitis: a candidate for disease-modifying strategy
@en
Atopic dermatitis: a candidate for disease-modifying strategy
@nl
prefLabel
Atopic dermatitis: a candidate for disease-modifying strategy
@ast
Atopic dermatitis: a candidate for disease-modifying strategy
@en
Atopic dermatitis: a candidate for disease-modifying strategy
@nl
P2093
P1433
P1476
Atopic dermatitis: a candidate for disease-modifying strategy
@en
P2093
P304
P356
10.1111/J.1398-9995.2012.02845.X
P407
P577
2012-08-01T00:00:00Z